Document Detail

Could azathioprine be considered as a therapeutic alternative in the treatment of alopecia areata? A pilot study.
MedLine Citation:
PMID:  20883409     Owner:  NLM     Status:  In-Process    
Alopecia areata is an autoimmune disease resulting in partial or total nonscarring hair loss and the treatment of severe alopecia areata is difficult. The aim of this study was to evaluate the efficacy and safety of azathioprine as a systemic monotherapy for moderate to severe alopecia areata. A total of 20 patients [14 men (70%) and six women (30%)] with minimum 6 months history of alopecia areata were included. The extent of scalp hair regrowth during and after the completion of the 6 months treatment was evaluated by the Severity of Alopecia Tool (the SALT score). The daily drug intake was calculated as 2 mg/kg of body weight. Mean duration of current episode of scalp hair loss was 26.4 (26.4 ± 17) months. Mean regrowth percentage was 52.3% (52.3 ± 38.4). Mean hair loss percentage before treatment was 72.7% (72.7 ± 28.3) compared with 33.5% (33.5 ± 30.7) after 6 months of azathioprine treatment. This showed a highly significant statistical difference (Paired t-test, CI 95% =21.5-54.1). Mean hair loss score (S(0) -S(5) ) before treatment was 3.9 (3.9 ± 1.6) and after 6 months of azathioprine treatment was 1.8 (1.8 ± 1.3). Assessment showed significant difference from baseline score (sign test, P < 0.0001). No significant statistical difference was observed with respect to gender before and after azathioprine treatment. Treatment with azathioprine as a systemic monotherapy clinically produces relevant improvement in moderate-to-severe alopecia areata. Generally azathioprine is a low-cost and well-tolerated drug and with controlled studies on larger number of patients, long-term efficacy and safety of this treatment should be investigated.
Susan Farshi; Parvin Mansouri; Farid Safar; Samad Rezaee Khiabanloo
Related Documents :
8041819 - Surgical treatment of axillary osmidrosis: an analysis of 343 cases.
21040129 - Clinical and echographic analysis of ablative fractionated carbon dioxide laser in the ...
22177169 - Nomograms to predict patency after microsurgical vasectomy reversal.
3292159 - 3 percent topical minoxidil compared with placebo for the treatment of chronic severe a...
19620039 - The efficacy of latanoprost in the treatment of alopecia areata of eyelashes and eyebrows.
18380209 - Skin rejuvenation in asian skin: the analysis of clinical effects and basic mechanisms ...
12567069 - Paranasal sinus development: a radiographic study.
16854209 - Primary rhinoplasty in unilateral cleft patients: the "limited open" approach and other...
9500719 - Tenoxicam, a non-steroid anti-inflammatory drug, is unable to increase the response rat...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  International journal of dermatology     Volume:  49     ISSN:  1365-4632     ISO Abbreviation:  Int. J. Dermatol.     Publication Date:  2010 Oct 
Date Detail:
Created Date:  2010-10-04     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0243704     Medline TA:  Int J Dermatol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1188-93     Citation Subset:  IM    
Copyright Information:
© 2010 The International Society of Dermatology.
Department of Dermatology, Tehran University of Medical Sciences, Imam Hospital, Tehran, Iran.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Modified gluteal-fold flap for the reconstruction of vulvovaginal defects.
Next Document:  Tamoxifen vs. non-tamoxifen treatment for advanced melanoma: a meta-analysis.